Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Citigroup Inc. (C) vs Inovio Pharmaceuticals Inc (INO) Price & Performance

Citigroup Inc.Trade
Inovio Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Citigroup Inc. vs Inovio Pharmaceuticals Inc — how do they compare? Citigroup Inc. trades at $135.74 (market cap $226.82B), while Inovio Pharmaceuticals Inc trades at $0.77 (market cap $76.09M). The key difference: Citigroup Inc. is far larger — about 2980.9× Inovio Pharmaceuticals Inc's market cap, and Citigroup Inc. pays a 1.98% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

CINO
Market Cap
$226.82B$76.09M
Sector
FinancialsHealth
52-Week High
$145.67$2.87
52-Week Low
$92.59$0.66
Dividend Yield
1.98%
Enterprise Value
$47.10M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Citigroup Inc.

Citigroup Inc. is a diversified financial services holding company that provides a broad range of financial services to consumer and corporate customers. The Company services include investment banking, retail brokerage, corporate banking, and cash management products and services. Citigroup serves customers globally.

Read more on C

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Read more on INO